Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

1,220

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

May 28, 2024

Study Completion Date

May 28, 2024

Conditions
Atopic Dermatitis Eczema
Interventions
DRUG

ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%

ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%

Trial Locations (92)

11415

Arcutis Clinical Site 96, Kew Gardens

14623

Arcutis Clinical Site 82, Rochester

15213

Arcutis Clinical Site 25, Pittsburgh

17033

Arcutis Clinical Site 53, Hershey

19073

Arcutis Clinical Site 64, Newtown Square

20850

Arcutis Clinical Site 76, Rockville

22015

Arcutis Clinical Site 51, Burke

23502

Arcutis Clinical Site 40, Norfolk

27262

Arcutis Clinical Site 19, High Point

29407

Arcutis Clinical Site 77, Charleston

29420

Clinical Site 33, North Charleston

29425

Arcutis Clinical Site 41, Charleston

29486

Arcutis Clinical Site 91, Summerville

30328

Arcutis Clinical Site 47, Sandy Springs

32256

Clinical Site 04, Jacksonville

32771

Arcutis Clinical Site 29, Sanford

33021

Arcutis Clinical Site 103, Hollywood

33134

Arcutis Clinical Site 59, Coral Gables

33146

Arcutis Clinical Site 72, Coral Gables

33162

Arcutis Clinical Site 67, Miami

33173

Arcutis Clinical Site 95, Miami

33174

Arcutis Clinical Site 68, Miami

33449

Arcutis Clinical Site 138, Wellington

33484

Arcutis Clinical Site 79, Delray Beach

33613

Clinical Site 01, Tampa

33770

Arcutis Clinical Site 15, Largo

Arcutis Clinical Site 13, Rolling Meadows

35209

Arcutis Clinical Site 112, Birmingham

35244

Arcutis Clinical Site 73, Birmingham

37130

Arcutis Clinical Site 60, Murfreesboro

40217

Clinical Site 03, Louisville

46168

Clinical Site 22, Plainfield

47129

Arcutis Clinical Site 93, Clarksville

47906

Arcutis Clinical Site 114, West Lafayette

48038

Arcutis Clinical Site 58, Clinton Township

48084

Arcutis Clinical Site 132, Troy

48202

Arcutis Clinical Site 66, Detroit

48346

Arcutis Clinical Site 88, Clarkston

48706

Arcutis Clinical Site 94, Bay City

53142

Arcutis Clinical Site 133, Kenosha

55112

Clinical Site 10, New Brighton

64506

Arcutis Clinical Site 102, Saint Joseph

70006

Arcutis Clinical Site 24, Metairie

70433

Arcutis Clinical Site 80, Covington

70605

Arcutis Clinical Site 85, Lake Charles

72022

Arcutis Clinical Site 106, Bryant

72916

Arcutis Clinical Site 116, Fort Smith

75034

Arcutis Clinical Site 126, Frisco

76011

Arcutis Clinical Site 34, Arlington

76051

Arcutis Clinical Site 118, Grapevine

77030

Arcutis Clinical Site 48, Houston

77056

Arcutis Clinical Site 35, Houston

77401

Arcutis Clinical Site 84, Bellaire

77494

Arcutis Clinical Site 109, Katy

77845

Arcutis Clinical Site 21, College Station

78213

Clinical Site 20, San Antonio

78218

Arcutis Clinical Site 49, San Antonio

78759

Clinical Site 23, Austin

80112

Arcutis Clinical Site 123, Centennial

83706

Arcutis Clinical Site 145, Boise

84058

Arcutis Clinical Site 74, Orem

84088

Arcutis Clinical Site 36, West Jordan

85255

Arcutis Clinical Site 63, Scottsdale

89509

Arcutis Clinical Site 62, Reno

90212

Arcutis Clinical Site 69, Beverly Hills

90301

Arcutis Clinical Site 81, Inglewood

90404

Arcutis Clinical Site 31, Santa Monica

91320

Arcutis Clinical Site 130, Thousand Oaks

94132

Clinical Site 08, San Francisco

97030

Arcutis Clinical Site 17, Gresham

97210

Arcutis Clinical Site 108, Portland

97223

Arcutis Clinical Site 16, Portland

97239

Arcutis Clinical Site 14, Portland

99202

Arcutis Clinical Site 12, Spokane

08520

Arcutis Clinical Site 71, East Windsor

02919

Arcutis Clinical Site 101, Johnston

T2J 7E1

Arcutis Clinical Site 70, Calgary

V3R 6A7

Arcutis Clinical Site 27, Surrey

R3M 3Z4

Arcutis Clinical Site 55, Winnipeg

E3B 1G9

Arcutis Clinical Site 50, Fredericton

L1S 7K8

Arcutis Clinical Site 43, Ajax

N6H 5L5

Arcutis Clinical Site 52, London

L3P 1X3

Clinical Site 11, Markham

L5H 1G9

Clinical Site 46, Mississauga

H2X 2V1

Arcutis Clinical Site 46, Montréal

Arcutis Clinical Site 45, Montreal

K9J 5K2

Arcutis Clinical Site 61, Peterborough

M4W 2N4

Arcutis Clinical Site 54, Toronto

N2J 1C4

Arcutis Clinical Site 39, Waterloo

N8W 1E6

Clinical Site 09, Windsor

J2B 5L4

Arcutis Clinical Site 26, Drummondville

H3Z 2S6

Arcutis Clinical Site 56, Montreal

Sponsors
All Listed Sponsors
lead

Arcutis Biotherapeutics, Inc.

INDUSTRY

NCT04804605 - Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis | Biotech Hunter | Biotech Hunter